Cancer Survivors Network: Escozine for Stage IV
So it has been 8+ years and 8,302 cancer patients
Escozine, currently in pre-clinical trials at the University of California, San Diego, Moores Cancer Center. Escozine is derived from the Caribbean blue scorpion venom – Rhopalurus, Family Buthidae. "Medolife is the scientific bridge between conventional cancer therapies and natural approaches. An eight year, open-label clinical study involving 8,302 cancer patients, representing a wide spectrum of cancer types, showed that blue scorpion venom had an 89.5% success rate in the quality of life for subjects in the study. Thousands of stage four cancer patients, who were given months to live, are still alive today years after first taking the blue scorpion venom. Escozine has been used in combination with chemotherapy, radiation, hormone therapy and other conventional treatments."
Me thinks FDA IND is already Approved, jmhtto
